Oral motor performance following central dopamine receptor blockade
Identifieur interne : 000F45 ( Istex/Curation ); précédent : 000F44; suivant : 000F46Oral motor performance following central dopamine receptor blockade
Auteurs : Douglas L. Jones [Canada] ; Gordon J. Mogenson [Canada]Source :
- European Journal of Pharmacology [ 0014-2999 ] ; 1979.
Abstract
Oral motor responses were recorded in water-deprived rats receiving injections of spiroperidol, the dopamine blocker, into the nucleus accumbens and caudate nucleus. Spiroperidol injected into the nucleus accumbens resulted in dose dependent decreases in lap volume and tongue extension. Injections of spiroperidol into adjacent sites or into the caudate nucleus did not significantly reduce lap volume even with an 8 fold larger dose administered into the caudate. These observations implicate the mesolimbic dopaminergic projections to the nucleus accumbens in oral motor responses and indicate the need for systematic comparisons of the contributions of mesolimbic and nigrostriatal dopaminergic systems to ingestive behaviors.
Url:
DOI: 10.1016/0014-2999(79)90019-0
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F45
Links to Exploration step
ISTEX:D085F53FD887E4DAD905DA17F86AA6B249AB25E6Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Oral motor performance following central dopamine receptor blockade</title>
<author><name sortKey="Jones, Douglas L" sort="Jones, Douglas L" uniqKey="Jones D" first="Douglas L." last="Jones">Douglas L. Jones</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Physiology, University of Western Ontario, London, Ontario, Canada N6A 5C1</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Physiology, University of Western Ontario, London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mogenson, Gordon J" sort="Mogenson, Gordon J" uniqKey="Mogenson G" first="Gordon J." last="Mogenson">Gordon J. Mogenson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Physiology, University of Western Ontario, London, Ontario, Canada N6A 5C1</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Physiology, University of Western Ontario, London, Ontario</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D085F53FD887E4DAD905DA17F86AA6B249AB25E6</idno>
<date when="1979" year="1979">1979</date>
<idno type="doi">10.1016/0014-2999(79)90019-0</idno>
<idno type="url">https://api-v5.istex.fr/document/D085F53FD887E4DAD905DA17F86AA6B249AB25E6/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F45</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F45</idno>
<idno type="wicri:Area/Istex/Curation">000F45</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">Oral motor performance following central dopamine receptor blockade</title>
<author><name sortKey="Jones, Douglas L" sort="Jones, Douglas L" uniqKey="Jones D" first="Douglas L." last="Jones">Douglas L. Jones</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Physiology, University of Western Ontario, London, Ontario, Canada N6A 5C1</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Physiology, University of Western Ontario, London, Ontario</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mogenson, Gordon J" sort="Mogenson, Gordon J" uniqKey="Mogenson G" first="Gordon J." last="Mogenson">Gordon J. Mogenson</name>
<affiliation wicri:level="1"><mods:affiliation>Department of Physiology, University of Western Ontario, London, Ontario, Canada N6A 5C1</mods:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Physiology, University of Western Ontario, London, Ontario</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">European Journal of Pharmacology</title>
<title level="j" type="abbrev">EJP</title>
<idno type="ISSN">0014-2999</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1979">1979</date>
<biblScope unit="volume">59</biblScope>
<biblScope unit="issue">1–2</biblScope>
<biblScope unit="page" from="11">11</biblScope>
<biblScope unit="page" to="21">21</biblScope>
</imprint>
<idno type="ISSN">0014-2999</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0014-2999</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Oral motor responses were recorded in water-deprived rats receiving injections of spiroperidol, the dopamine blocker, into the nucleus accumbens and caudate nucleus. Spiroperidol injected into the nucleus accumbens resulted in dose dependent decreases in lap volume and tongue extension. Injections of spiroperidol into adjacent sites or into the caudate nucleus did not significantly reduce lap volume even with an 8 fold larger dose administered into the caudate. These observations implicate the mesolimbic dopaminergic projections to the nucleus accumbens in oral motor responses and indicate the need for systematic comparisons of the contributions of mesolimbic and nigrostriatal dopaminergic systems to ingestive behaviors.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000F45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:D085F53FD887E4DAD905DA17F86AA6B249AB25E6 |texte= Oral motor performance following central dopamine receptor blockade }}
This area was generated with Dilib version V0.6.29. |